Sandi E Matarangas, DPM
Podiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Matarangas’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$104,699
Medicare paid this office $104,699 for 271 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 182 | $43,720 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $11,118 | $42 |
| Return visit (30+ min) | 42 | $9,975 | $126 |
| New patient visit (30+ min) | 91 | $8,273 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $4,853 | $135 |
See all 9 services
| Short return visit (20+ min) | 182 | $43,720 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $11,118 | $42 |
| Return visit (30+ min) | 42 | $9,975 | $126 |
| New patient visit (30+ min) | 91 | $8,273 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $4,853 | $135 |
| Removal of noncancer thickened skin growth, 2-4 growths | 26 | $4,561 | $77 |
| New patient visit (45+ min) | 27 | $4,168 | $154 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $3,267 | $74 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $18 | None |
Procedures Medicare counted
| Removal of nail tissue | 350 | More than 80% of doctors who do this |
| Removal of tissue | 50 | More than 78% of doctors who do this |
| Removal or shaving of skin growth | 112 | More than 85% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
271 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 17% · Women 58% · Also on Medicaid 19% · Health risk score 1.60. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 35% · Coronary heart disease 25% · Heart failure 21% · Atrial fibrillation 21% · Depression 18% · Cancer 12% · COPD 12% · Dementia 11% · Stroke 11%.
The office billed $411,900, Medicare allowed $138,639 and paid $104,699; for 1,319 services of 37 kinds; $454 of it was for drugs given in the office and $104,245 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 271 | 1,319 | 76 | 1.60 | $411,900 | $104,699 |
| 2023 | 246 | 1,255 | 75 | 1.62 | $383,223 | $96,570 |
| 2022 | 234 | 1,216 | 75 | 1.60 | $381,448 | $94,783 |
| 2021 | 197 | 1,136 | 76 | 1.82 | $334,783 | $89,976 |
| 2020 | 199 | 1,039 | 76 | 2.27 | $267,411 | $66,280 |
| 2019 | 259 | 953 | 75 | 2.07 | $260,917 | $64,168 |
| 2018 | 196 | 1,234 | 75 | 1.85 | $324,630 | $80,487 |
| 2017 | 196 | 1,071 | 75 | 1.92 | $221,119 | $63,588 |
| 2016 | 198 | 1,190 | 74 | 1.98 | $220,879 | $62,829 |
| 2015 | 200 | 988 | 75 | 2.06 | $195,394 | $62,424 |
| 2014 | 209 | 1,125 | 74 | 1.88 | $197,960 | $65,688 |
| 2013 | 195 | 897 | 74 | 1.87 | $111,208 | $52,565 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 171 | $39,812 | $83 |
| Removal of fingernails or toenails, 6 or more nails | 106 | $10,298 | $41 |
| New patient visit (30+ min) | 91 | $9,004 | $99 |
| Return visit (30+ min) | 37 | $7,621 | $115 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $4,750 | $132 |
| Removal of noncancer thickened skin growth, 2-4 growths | 30 | $4,510 | $82 |
| Removal of noncancer thickened skin growth, 1 growth | 34 | $4,296 | $74 |
| New patient visit (45+ min) | 15 | $2,062 | $137 |
| Removal of fingernails or toenails, 1-5 nails | 17 | $640 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $16 | None |
2022: 12 services
| Short return visit (20+ min) | 154 | $32,464 | $84 |
| Return visit (30+ min) | 42 | $11,403 | $119 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $10,058 | $132 |
| Removal of fingernails or toenails, 6 or more nails | 102 | $8,496 | $40 |
| New patient visit (30+ min) | 63 | $5,886 | $93 |
| Removal of noncancer thickened skin growth, 2-4 growths | 31 | $4,739 | $78 |
| New patient visit (45+ min) | 28 | $3,480 | $124 |
| Removal of skin of fingernail or toenail | 14 | $2,766 | $173 |
| Removal of noncancer thickened skin growth, 1 growth | 28 | $2,216 | $65 |
| Removal of fingernails or toenails, 1-5 nails | 16 | $600 | $32 |
| Administration of influenza virus vaccine | 13 | $493 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $17 | None |
2021: 12 services
| Short return visit (20+ min) | 137 | $33,185 | $85 |
| Return visit (30+ min) | 50 | $12,499 | $121 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $8,652 | $129 |
| Removal of fingernails or toenails, 6 or more nails | 87 | $8,180 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $4,576 | $76 |
| New patient visit (30+ min) | 45 | $4,523 | $101 |
| New patient visit (45+ min) | 20 | $3,168 | $158 |
| Removal of noncancer thickened skin growth, 1 growth | 21 | $2,056 | $71 |
| Removal of fingernails or toenails, 1-5 nails | 15 | $444 | $30 |
| Administration of influenza virus vaccine | 18 | $390 | $22 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $244 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $15 | None |
2020: 11 services
| Short return visit (20+ min) | 147 | $26,654 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 112 | $8,160 | $37 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $5,426 | $129 |
| Return visit (30+ min) | 23 | $4,216 | $98 |
| New patient visit (30+ min) | 38 | $3,213 | $85 |
| Removal of noncancer thickened skin growth, 2-4 growths | 24 | $3,162 | $74 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $2,410 | $59 |
| New patient visit (45+ min) | 15 | $2,097 | $140 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $939 | $72 |
| Removal of fingernails or toenails, 1-5 nails | 13 | $431 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $21 | None |
2019: 8 services
| Short return visit (20+ min) | 184 | $32,084 | $65 |
| New patient visit (30+ min) | 78 | $6,804 | $87 |
| Removal of fingernails or toenails, 6 or more nails | 78 | $4,601 | $39 |
| Return visit (30+ min) | 26 | $3,633 | $93 |
| New patient visit (45+ min) | 19 | $2,795 | $147 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $979 | $54 |
| New patient visit (15+ min) | 17 | $961 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $16 | None |
2018: 10 services
| Short return visit (20+ min) | 144 | $25,511 | $64 |
| Return visit (30+ min) | 40 | $10,235 | $95 |
| Removal of fingernails or toenails, 6 or more nails | 90 | $8,332 | $41 |
| New patient visit (30+ min) | 64 | $5,691 | $89 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $4,572 | $90 |
| New patient visit (45+ min) | 20 | $2,861 | $143 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,505 | $46 |
| Removal of noncancer thickened skin growth, 2-4 growths | 12 | $1,478 | $57 |
| Injection of drug or substance under skin or into muscle | 11 | $505 | $20 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $35 | None |
2017: 12 services
| Short return visit (20+ min) | 152 | $24,319 | $60 |
| Removal of fingernails or toenails, 6 or more nails | 84 | $7,288 | $38 |
| Return visit (30+ min) | 45 | $6,778 | $90 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $5,407 | $106 |
| New patient visit (45+ min) | 27 | $3,749 | $139 |
| New patient visit (30+ min) | 36 | $2,902 | $81 |
| Strapping, unna boot | 12 | $1,657 | $55 |
| Removal of skin of fingernail or toenail | 12 | $1,654 | $138 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $1,625 | $42 |
| Removal of noncancer thickened skin growth, 2-4 growths | 19 | $1,505 | $49 |
| Injection of drug or substance under skin or into muscle | 12 | $510 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $34 | None |
2016: 8 services
| Short return visit (20+ min) | 159 | $25,186 | $61 |
| Removal of fingernails or toenails, 6 or more nails | 108 | $9,538 | $39 |
| Return visit (30+ min) | 26 | $5,221 | $97 |
| Strapping, unna boot | 17 | $5,194 | $58 |
| New patient visit (30+ min) | 54 | $4,666 | $86 |
| Removal of noncancer thickened skin growth, 2-4 growths | 18 | $1,991 | $51 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $1,646 | $44 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $34 | None |
2015: 5 services
| Short return visit (20+ min) | 167 | $30,593 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 112 | $11,373 | $43 |
| New patient visit (30+ min) | 49 | $4,868 | $99 |
| Removal of noncancer thickened skin growth, 2-4 growths | 21 | $2,249 | $58 |
| Removal of noncancer thickened skin growth, 1 growth | 20 | $1,512 | $50 |
2014: 6 services
| Short return visit (20+ min) | 169 | $32,903 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 123 | $11,609 | $40 |
| New patient visit (30+ min) | 69 | $6,173 | $89 |
| Removal of noncancer thickened skin growth, 2-4 growths | 29 | $2,669 | $53 |
| Removal of inflamed or infected skin, up to 10% of body surface | 11 | $2,023 | $49 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $1,479 | $44 |
2013: 8 services
| Short return visit (20+ min) | 137 | $23,345 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 107 | $8,825 | $42 |
| New patient visit (30+ min) | 79 | $7,448 | $94 |
| Removal of inflamed or infected skin, up to 10% of body surface | 16 | $2,847 | $51 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $1,447 | $54 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $694 | $46 |
| Injection of drug or substance under skin or into muscle | 11 | $438 | $26 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $21 | None |
Drugs they prescribed that Part D paid
$9,401
Pharmacies billed $9,401 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (42 of 507) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
505 generic and fewer than 11 brand-name prescriptions · $9,401 in drug cost · 104 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clotrimazole | 140 | $3,983 | $28 |
| Gabapentin | 71 | $553 | $8 |
| Celecoxib | 15 | $401 | $27 |
| Nabumetone | 12 | $382 | $32 |
| Cephalexin | 40 | $297 | $7 |
See all 13 drugs
| Clotrimazole | 140 | $3,983 | $28 |
| Gabapentin | 71 | $553 | $8 |
| Celecoxib | 15 | $401 | $27 |
| Nabumetone | 12 | $382 | $32 |
| Cephalexin | 40 | $297 | $7 |
| Hydrocodone-Acetaminophen | 38 | $250 | $7 |
| Colchicine | 23 | $221 | $10 |
| Doxycycline Hyclate | 24 | $195 | $8 |
| Ammonium Lactate | 11 | $140 | $13 |
| Amoxicillin-Clavulanate Potass | 16 | $94 | $6 |
| Terbinafine | 14 | $49 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $40 | $3 |
| Amlodipine Besylate | 12 | $0 | $0 |
Year by year
| 2024 | 507 | 185 | 8% (42) | None | $9,401 |
| 2023 | 371 | 150 | 13% (47) | None | $7,410 |
| 2022 | 352 | 139 | 13% (46) | None | $10,245 |
| 2021 | 360 | 126 | 16% (57) | None | $7,909 |
| 2020 | 297 | 107 | 10% (29) | None | $7,921 |
| 2019 | 286 | 116 | 14% (39) | None | $7,597 |
| 2018 | 253 | 100 | 9% (22) | None | $6,789 |
| 2017 | 255 | 100 | None | 5% | $11,270 |
| 2016 | 274 | 84 | 10% (27) | 7% | $13,092 |
| 2015 | 210 | 78 | 13% (28) | None | $6,005 |
| 2014 | 226 | 93 | 13% (30) | None | $5,662 |
| 2013 | 312 | 122 | 14% (45) | 4% | $7,054 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Clotrimazole | 67 | $2,667 | $40 |
| Ammonium Lactate | 12 | $438 | $36 |
| Gabapentin | 47 | $349 | $7 |
| Hydrocodone-Acetaminophen | 37 | $335 | $9 |
| Doxycycline Hyclate | 19 | $259 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $253 | $17 |
| Cephalexin | 36 | $251 | $7 |
| Ciprofloxacin | 12 | $168 | $14 |
| Terbinafine | 15 | $107 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $52 | $4 |
2022: 11 drugs
| Clotrimazole | 57 | $2,357 | $41 |
| Colchicine | 17 | $407 | $24 |
| Hydrocodone-Acetaminophen | 45 | $343 | $8 |
| Triamcinolone Acetonide | 12 | $235 | $20 |
| Doxycycline Hyclate | 18 | $227 | $13 |
| Amoxicillin-Clavulanate Potass | 21 | $223 | $11 |
| Cephalexin | 24 | $202 | $8 |
| Gabapentin | 32 | $142 | $4 |
| Terbinafine | 13 | $130 | $10 |
| Sulfamethoxazole-Trimethoprim | 17 | $95 | $6 |
| Levofloxacin | 11 | $59 | $5 |
2021: 13 drugs
| Clotrimazole | 46 | $1,719 | $37 |
| Lidocaine | 13 | $1,422 | $109 |
| Ammonium Lactate | 20 | $598 | $30 |
| Hydrocodone-Acetaminophen | 42 | $305 | $7 |
| Amoxicillin-Clavulanate Potass | 24 | $274 | $11 |
| Triamcinolone Acetonide | 14 | $260 | $19 |
| Mupirocin | 14 | $209 | $15 |
| Ciprofloxacin | 21 | $192 | $9 |
| Cephalexin | 25 | $163 | $7 |
| Doxycycline Hyclate | 11 | $159 | $14 |
| Tramadol | 12 | $98 | $8 |
| Sulfamethoxazole-Trimethoprim | 18 | $93 | $5 |
| Gabapentin | 21 | $69 | $3 |
2020: 10 drugs
| Lidocaine | 21 | $1,355 | $65 |
| Clotrimazole | 23 | $1,018 | $44 |
| Amoxicillin-Clavulanate Potass | 31 | $489 | $16 |
| Ammonium Lactate | 12 | $321 | $27 |
| Doxycycline Hyclate | 13 | $301 | $23 |
| Diclofenac | 12 | $287 | $24 |
| Gabapentin | 33 | $271 | $8 |
| Cephalexin | 25 | $158 | $6 |
| Hydrocodone-Acetaminophen | 21 | $129 | $6 |
| Sulfamethoxazole-Trimethoprim | 17 | $102 | $6 |
2019: 9 drugs
| Econazole Nitrate | 11 | $816 | $74 |
| Gabapentin | 32 | $526 | $16 |
| Lidocaine | 14 | $455 | $32 |
| Hydrocodone-Acetaminophen | 25 | $454 | $18 |
| Amoxicillin-Clavulanate Potass | 20 | $239 | $12 |
| Sulfamethoxazole-Trimethoprim | 22 | $157 | $7 |
| Cephalexin | 19 | $147 | $8 |
| Terbinafine | 18 | $118 | $7 |
| Baclofen | 12 | $53 | $4 |
2018: 8 drugs
| Gabapentin | 39 | $736 | $19 |
| Lidocaine | 22 | $486 | $22 |
| Amoxicillin-Clavulanate Potass | 27 | $417 | $15 |
| Hydrocodone-Acetaminophen | 15 | $326 | $22 |
| Ammonium Lactate | 11 | $313 | $28 |
| Sulfamethoxazole-Trimethoprim | 24 | $204 | $8 |
| Ciprofloxacin | 11 | $154 | $14 |
| Cephalexin | 20 | $125 | $6 |
2017: 6 drugs
| Amoxicillin-Clavulanate Potass | 40 | $522 | $13 |
| Gabapentin | 37 | $400 | $11 |
| Lidocaine | 16 | $275 | $17 |
| Cephalexin | 31 | $217 | $7 |
| Mupirocin | 14 | $119 | $8 |
| Terbinafine | 12 | $84 | $7 |
2016: 9 drugs
| Doxycycline Hyclate | 16 | $633 | $40 |
| Ammonium Lactate | 20 | $550 | $28 |
| Gabapentin | 40 | $527 | $13 |
| Amoxicillin-Clavulanate Potass | 31 | $468 | $15 |
| Lidocaine | 21 | $408 | $19 |
| Hydrocodone-Acetaminophen | 14 | $340 | $24 |
| Mupirocin | 14 | $144 | $10 |
| Cephalexin | 16 | $83 | $5 |
| Sulfamethoxazole-Trimethoprim | 14 | $61 | $4 |
2015: 8 drugs
| Doxycycline Hyclate | 11 | $544 | $49 |
| Hydrocodone-Acetaminophen | 15 | $490 | $33 |
| Lidocaine | 22 | $380 | $17 |
| Gabapentin | 33 | $321 | $10 |
| Amoxicillin-Clavulanate Potass | 18 | $295 | $16 |
| Triamcinolone Acetonide | 14 | $219 | $16 |
| Mupirocin | 12 | $182 | $15 |
| Cephalexin | 15 | $79 | $5 |
2014: 8 drugs
| Econazole Nitrate | 11 | $667 | $61 |
| Hydrocodone-Acetaminophen | 20 | $432 | $22 |
| Amox Tr-Potassium Clavulanate | 21 | $385 | $18 |
| Lidocaine | 15 | $384 | $26 |
| Gabapentin | 48 | $376 | $8 |
| Mupirocin | 22 | $248 | $11 |
| Ammonium Lactate | 11 | $180 | $16 |
| Cephalexin | 18 | $108 | $6 |
2013: 10 drugs
| Lidocaine | 32 | $840 | $26 |
| Ammonium Lactate | 31 | $563 | $18 |
| Amox Tr-Potassium Clavulanate | 18 | $476 | $26 |
| Econazole Nitrate | 28 | $422 | $15 |
| Mupirocin | 30 | $389 | $13 |
| Gabapentin | 25 | $191 | $8 |
| Cephalexin | 23 | $157 | $7 |
| Terbinafine | 18 | $156 | $9 |
| Hydrocodone-Acetaminophen | 32 | $140 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $65 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871600239
- Licence
- CA E4328
- Trained
- California School of Podiatric Medicine, 1999
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X); Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 227 N Jackson Ave, San Jose, CA, 95116
- NPI first listed
- 2006-08-23
- NPI last updated
- 2020-12-07
- NPI record certified
- 2020-12-07
This is when the NPI record was last certified, not a medical board exam.